Boston, MA, United States of America

Erhan I Altinoglu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • State College, PA (US) (2014)
  • Boston, MA (US) (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Erhan I Altinoglu: Innovator in Nanoparticle Technology

Introduction

Erhan I Altinoglu is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of nanoparticle technology, particularly in the development of bioconjugated calcium phosphosilicate nanoparticles. With a total of 2 patents, his work focuses on enhancing targeted drug delivery and imaging techniques.

Latest Patents

One of his latest patents involves the bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo. This innovative approach allows for the stable encapsulation of chemotherapy and imaging agents within nanoparticles, protecting them from environmental interactions until they reach the target cells. The nanoparticles dissolve at intracellular pH, releasing the agents precisely where they are needed, thus minimizing systemic exposure while maximizing therapeutic efficacy.

Another notable patent describes the use of nano-encapsulated photosensitizers in photodynamic therapy. By encapsulating photosensitizers in calcium phosphate nanoparticles, the half-life and absorption of these agents are significantly improved. This advancement enhances the effectiveness of treatments for tumors and aids in imaging target tissues, ultimately contributing to better cancer management.

Career Highlights

Erhan I Altinoglu is affiliated with the Penn State Research Foundation, where he continues to push the boundaries of nanoparticle research. His innovative work has garnered attention in the scientific community, leading to advancements in cancer treatment methodologies.

Collaborations

He has collaborated with notable colleagues such as James H Adair and Mark Kester, further enriching his research endeavors and expanding the impact of his inventions.

Conclusion

Erhan I Altinoglu's contributions to nanoparticle technology exemplify the potential of innovative approaches in medicine. His patents reflect a commitment to improving targeted therapies and imaging techniques, paving the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…